Patents by Inventor Jay A. Warren

Jay A. Warren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9962100
    Abstract: Methods, systems, and devices for signal analysis in an implantable cardiac device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. Analysis of the apparent width of detected events is used to determine whether overdetection is occurring. If overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: May 8, 2018
    Assignee: Cameron Health, Inc.
    Inventors: Venugopal Allavatam, Jay A. Warren, Rick Sanghera
  • Patent number: 9878172
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: January 30, 2018
    Assignee: Cameron Health, Inc.
    Inventors: Venugopal Allavatam, Surekha Palreddy, Rick Sanghera, Jay A. Warren
  • Publication number: 20180021590
    Abstract: Signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, detected events are analyzed to identify changes in detected event amplitudes. When detected event amplitudes are dissimilar from one another, a first set of detection parameters may be invoked, and, when detected event amplitudes are similar to one another, a second set of detection parameters may be invoked. Additional examples determine whether the calculated heart rate is “high” or “low,” and then may select a third set of detection parameters for use when the calculated heart rate is high.
    Type: Application
    Filed: September 29, 2017
    Publication date: January 25, 2018
    Applicant: CAMERON HEALTH, INC.
    Inventors: VENUGOPAL ALLAVATAM, SUREKHA PALREDDY, RICK SANGHERA, JAY A. WARREN
  • Publication number: 20180000410
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. Several examples emphasize the use of morphology analysis using correlation to static templates and/or inter-event correlation analysis.
    Type: Application
    Filed: September 14, 2017
    Publication date: January 4, 2018
    Applicant: CAMERON HEALTH, INC.
    Inventors: JAY A. WARREN, RICK SANGHERA, VENUGOPAL ALLAVATAM, SUREKHA PALREDDY
  • Patent number: 9802056
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some illustrative examples, detected events are analyzed to identify changes in detected event amplitudes. When detected event amplitudes are dissimilar from one another, a first set of detection parameters may be invoked, and, when detected event amplitudes are similar to one another, a second set of detection parameters may be invoked. Additional methods determine whether the calculated heart rate is “high” or “low,” and then may select a third set of detection parameters for use when the calculated heart rate is high.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: October 31, 2017
    Assignee: Cameron Health, Inc.
    Inventors: Venugopal Allavatam, Surekha Palreddy, Rick Sanghera, Jay A. Warren
  • Patent number: 9763619
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. Several examples emphasize the use of morphology analysis using correlation to static templates and/or inter-event correlation analysis.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: September 19, 2017
    Assignee: Cameron Health, Inc.
    Inventors: Jay A. Warren, Rick Sanghera, Venugopal Allavatam, Surekha Palreddy
  • Patent number: 9764152
    Abstract: The implantable cardiac treatment system of the present invention is capable of choosing the most appropriate electrode vector to sense within a particular patient. In certain embodiments, the implantable cardiac treatment system determines the most appropriate electrode vector for continuous sensing based on which electrode vector results in the greatest signal amplitude, or some other useful metric such as signal-to-noise ratio (SNR). The electrode vector possessing the highest quality as measured using the metric is then set as the default electrode vector for sensing. Additionally, in certain embodiments of the present invention, a next alternative electrode vector is selected based on being generally orthogonal to the default electrode vector. In yet other embodiments of the present invention, the next alternative electrode vector is selected based on possessing the next highest quality metric after the default electrode vector.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: September 19, 2017
    Assignee: Cameron Health, Inc.
    Inventors: Jay A. Warren, Gust H. Bardy
  • Publication number: 20170120064
    Abstract: The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not.
    Type: Application
    Filed: January 16, 2017
    Publication date: May 4, 2017
    Applicant: CAMERON HEALTH, INC.
    Inventors: Alan H. Ostroff, Jay A. Warren, Gust H. Bardy
  • Patent number: 9636514
    Abstract: Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device. Some example methods and devices use a first counter to track benign cardiac activity during therapy preparations and a second counter to track shockable cardiac activity once therapy is ready. Therapy can then be delivered if or when the second counter exceeds the first counter.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: May 2, 2017
    Assignee: Cameron Health, Inc.
    Inventors: Jay A. Warren, Rick Sanghera, Venugopal Allavatam
  • Publication number: 20170095672
    Abstract: The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 6, 2017
    Applicant: CAMERON HEALTH, INC.
    Inventors: Alan H. Ostroff, Jay A. Warren, Gust H. Bardy
  • Patent number: 9555259
    Abstract: The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: January 31, 2017
    Assignee: CAMERON HEALTH INC.
    Inventors: Alan H. Ostroff, Jay A. Warren, Gust H. Bardy
  • Publication number: 20160236001
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 18, 2016
    Applicant: CAMERON HEALTH INC.
    Inventors: Venugopal Allavatam, Surekha Palreddy, Rick Sanghera, Jay A. Warren
  • Publication number: 20160235998
    Abstract: The implantable cardiac treatment system of the present invention is capable of choosing the most appropriate electrode vector to sense within a particular patient. In certain embodiments, the implantable cardiac treatment system determines the most appropriate electrode vector for continuous sensing based on which electrode vector results in the greatest signal amplitude, or some other useful metric such as signal-to-noise ratio (SNR). The electrode vector possessing the highest quality as measured using the metric is then set as the default electrode vector for sensing. Additionally, in certain embodiments of the present invention, a next alternative electrode vector is selected based on being generally orthogonal to the default electrode vector. In yet other embodiments of the present invention, the next alternative electrode vector is selected based on possessing the next highest quality metric after the default electrode vector.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 18, 2016
    Applicant: CAMERON HEALTH INC.
    Inventors: Jay A. Warren, Gust H. Bardy
  • Patent number: 9345899
    Abstract: The implantable cardiac treatment system of the present invention is capable of choosing the most appropriate electrode vector to sense within a particular patient. In certain embodiments, the implantable cardiac treatment system determines the most appropriate electrode vector for continuous sensing based on which electrode vector results in the greatest signal amplitude, or some other useful metric such as signal-to-noise ratio (SNR). The electrode vector possessing the highest quality as measured using the metric is then set as the default electrode vector for sensing. Additionally, in certain embodiments of the present invention, a next alternative electrode vector is selected based on being generally orthogonal to the default electrode vector. In yet other embodiments of the present invention, the next alternative electrode vector is selected based on possessing the next highest quality metric after the default electrode vector.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: May 24, 2016
    Assignee: CAMERON HEALTH, INC.
    Inventors: Jay A. Warren, Gust H. Bardy
  • Patent number: 9339662
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: May 17, 2016
    Assignee: CAMERON HEALTH, INC.
    Inventors: Venugopal Allavatam, Surekha Palreddy, Rick Sanghera, Jay A. Warren
  • Publication number: 20160128630
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. Several examples emphasize the use of morphology analysis using correlation to static templates and/or inter-event correlation analysis.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 12, 2016
    Applicant: CAMERON HEALTH INC.
    Inventors: Jay A. Warren, Rick Sanghera, Venugopal Allavatam, Surekha Palreddy
  • Patent number: 9265432
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In some examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. Several examples emphasize the use of morphology analysis using correlation to static templates and/or inter-event correlation analysis.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: February 23, 2016
    Assignee: CAMERON HEALTH, INC.
    Inventors: Jay A. Warren, Rick Sanghera, Venugopal Allavatam, Surekha Palreddy
  • Publication number: 20160001090
    Abstract: The present invention is directed toward a detection architecture for use in implantable cardiac rhythm devices. The detection architecture of the present invention provides methods and devices for discriminating between arrhythmias. Moreover, by exploiting the enhanced specificity in the origin of the identified arrhythmia, the detection architecture can better discriminate between rhythms appropriate for device therapy and those that are not.
    Type: Application
    Filed: September 15, 2015
    Publication date: January 7, 2016
    Applicant: CAMERON HEALTH, INC.
    Inventors: Alan H. Ostroff, Jay A. Warren, Gust H. Bardy
  • Publication number: 20150375004
    Abstract: Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device by observing cardiac activity following an initial identification of a treatable condition. In some examples, cardiac activity that appears benign is quantified and a therapy confirmation threshold is adjusted according to how much apparently benign cardiac activity is seen after an initial identification of a treatable condition. In other examples, a new threshold is applied following the initial identification of treatable condition, removing historical data preceding the initial identification from subsequent therapy delivery decisions.
    Type: Application
    Filed: September 14, 2015
    Publication date: December 31, 2015
    Applicant: CAMERON HEALTH INC.
    Inventors: Jay A. Warren, Rick Sanghera, Venugopal Allavatam
  • Patent number: 9179853
    Abstract: Devices and methods for analyzing cardiac signal data. An illustrative method includes identifying a plurality of detected events and measuring intervals between the detected events for use in rate estimation. In the illustrative embodiment, a set of intervals is used to make the rate estimation by first discarding selected intervals from the set. The remaining intervals are then used to calculate an estimated interval, for example by averaging the remaining intervals.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: November 10, 2015
    Assignee: CAMERON HEALTH, INC.
    Inventors: Rick Sanghera, Venugopal Allavatam, Jay A. Warren, Mark R. Schroeder